Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy.

Literature DB >> 31626322

Hair Depigmentation and Hair Loss in Advanced Melanoma Treated with Combined Immunotherapy and Targeted Therapy.

Florentia Dimitriou¹, Joanna Mangana, Reinhard Dummer.

Abstract

Entities: Chemical

Keywords: hair depigmentation; hair loss; melanoma

Mesh：

Substances：

Year: 2020 PMID： 31626322 PMCID： PMC9128868 DOI： 10.2340/00015555-3355

Source DB: PubMed Journal: Acta Derm Venereol ISSN： 0001-5555 Impact factor: 3.875

× No keyword cloud information.

12 in total

1. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

Authors: Luzhou Xing; Zhenpeng Dai; Ali Jabbari; Jane E Cerise; Claire A Higgins; Weijuan Gong; Annemieke de Jong; Sivan Harel; Gina M DeStefano; Lisa Rothman; Pallavi Singh; Lynn Petukhova; Julian Mackay-Wiggan; Angela M Christiano; Raphael Clynes
Journal: Nat Med Date: 2014-08-17 Impact factor: 53.440

2. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.

Authors: A Gilhar; M Landau; B Assy; R Shalaginov; S Serafimovich; R S Kalish
Journal: J Invest Dermatol Date: 2001-12 Impact factor: 8.551

Review 3. Immune and molecular correlates in melanoma treated with immune checkpoint blockade.

Authors: Elizabeth H Byrne; David E Fisher
Journal: Cancer Date: 2017-06-01 Impact factor: 6.860

Review 4. Immune Checkpoint Blockade in Cancer Therapy.

Authors: Michael A Postow; Margaret K Callahan; Jedd D Wolchok
Journal: J Clin Oncol Date: 2015-01-20 Impact factor: 44.544

Review 5. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis.

Authors: Hansje-Eva Teulings; Jacqueline Limpens; Sophia N Jansen; Aeilko H Zwinderman; Johannes B Reitsma; Phyllis I Spuls; Rosalie M Luiten
Journal: J Clin Oncol Date: 2015-01-20 Impact factor: 44.544

Review 6. Understanding autoimmunity of vitiligo and alopecia areata.

Authors: Jillian F Rork; Mehdi Rashighi; John E Harris
Journal: Curr Opin Pediatr Date: 2016-08 Impact factor: 2.856

7. Alopecia areata with white hair regrowth: case report and review of poliosis.

Authors: Sheila Z Jalalat; John R Kelsoe; Philip R Cohen
Journal: Dermatol Online J Date: 2014-09-16

8. BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

Authors: Dennie T Frederick; Adriano Piris; Alexandria P Cogdill; Zachary A Cooper; Cecilia Lezcano; Cristina R Ferrone; Devarati Mitra; Andrea Boni; Lindsay P Newton; Chengwen Liu; Weiyi Peng; Ryan J Sullivan; Donald P Lawrence; F Stephen Hodi; Willem W Overwijk; Gregory Lizée; George F Murphy; Patrick Hwu; Keith T Flaherty; David E Fisher; Jennifer A Wargo
Journal: Clin Cancer Res Date: 2013-01-10 Impact factor: 12.531

9. Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma.

Authors: Florentia Dimitriou; Alexandra V Matter; Joanna Mangana; Mirjana Urosevic-Maiwald; Sara Micaletto; Ralph P Braun; Lars E French; Reinhard Dummer
Journal: J Immunother Date: 2019-01 Impact factor: 4.456